India-headquartered surgical robotics firm offering the SSi Mantra robot, the only system approved for telesurgery, with 138+ installs across 8 countries.
SS Innovations International Inc. is a medical technology company founded by Dr. Sudhir Srivastava, a robotic cardiac surgeon, with operations in Gurugram, India and Fort Lauderdale, Florida. The company develops, manufactures, and commercializes the SSi Mantra Surgical Robotic System, a modular platform featuring three to five robotic arms, an ergonomic surgeon command center, and a 32-inch 3D 4K monitor. The SSi Mantra 3 is the only surgical robot in the world to have received regulatory approval for telesurgery and tele-proctoring.
As of 2026, the system has been installed in 138 facilities across eight countries, with more than 7,300 surgical procedures completed, including 88 telesurgeries and 390 cardiac cases. The company has filed a 510(k) premarket notification with the FDA for clearance across general, urological, colorectal, gynecological, and cardiac surgery indications. Listed on NASDAQ under ticker SSII.
Primary type & automation activities this supplier delivers:
Modular surgical robot with 3-5 arms, 3D 4K visualization, and the world's first regulatory approval for telesurgery and tele-proctoring.
Contact SS Innovations International Inc.
WEBSITE
https://ssinnovations.comPHONE
+91-7337553469HEADQUARTERS
United States
Company Facts
Founded
2016
Primary Role
Manufacturer
Company Size
-
Primary Region
Asia-Pacific
Annual Sales
-
Funding Stage
-
Funding Total
-
